HRP20110666T1 - Uporaba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju motoričkih poremećaja povezanih s parkinsonovom bolesti - Google Patents

Uporaba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju motoričkih poremećaja povezanih s parkinsonovom bolesti Download PDF

Info

Publication number
HRP20110666T1
HRP20110666T1 HR20110666T HRP20110666T HRP20110666T1 HR P20110666 T1 HRP20110666 T1 HR P20110666T1 HR 20110666 T HR20110666 T HR 20110666T HR P20110666 T HRP20110666 T HR P20110666T HR P20110666 T1 HRP20110666 T1 HR P20110666T1
Authority
HR
Croatia
Prior art keywords
oxidopyridin
carboxamide
use according
disorders
cyclopropylmethoxy
Prior art date
Application number
HR20110666T
Other languages
English (en)
Croatian (hr)
Inventor
Delay-Goyet Philippe
Delgorge Claire
Menet Christine
Poughon Gilles
Ravinet-Trillou Christine
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of HRP20110666T1 publication Critical patent/HRP20110666T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
HR20110666T 2007-04-19 2008-04-16 Uporaba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju motoričkih poremećaja povezanih s parkinsonovom bolesti HRP20110666T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0702853A FR2915100B1 (fr) 2007-04-19 2007-04-19 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxalide pour le traitement des desordres moteurs lies a la maladie de parkinson
PCT/FR2008/000534 WO2008145841A1 (fr) 2007-04-19 2008-04-16 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson

Publications (1)

Publication Number Publication Date
HRP20110666T1 true HRP20110666T1 (hr) 2011-10-31

Family

ID=38712405

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110666T HRP20110666T1 (hr) 2007-04-19 2008-04-16 Uporaba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju motoričkih poremećaja povezanih s parkinsonovom bolesti

Country Status (33)

Country Link
US (1) US20100130554A1 (enExample)
EP (1) EP2146714B1 (enExample)
JP (1) JP5386478B2 (enExample)
KR (2) KR20150004885A (enExample)
CN (1) CN101663035B (enExample)
AR (1) AR066108A1 (enExample)
AT (1) ATE513548T1 (enExample)
AU (1) AU2008257322B2 (enExample)
BR (1) BRPI0810444A2 (enExample)
CA (1) CA2684174C (enExample)
CL (1) CL2008001136A1 (enExample)
CY (1) CY1111840T1 (enExample)
DK (1) DK2146714T3 (enExample)
EA (1) EA019194B1 (enExample)
ES (1) ES2367408T3 (enExample)
FR (1) FR2915100B1 (enExample)
HR (1) HRP20110666T1 (enExample)
IL (1) IL201448A (enExample)
JO (1) JO2678B1 (enExample)
MA (1) MA31367B1 (enExample)
ME (1) ME00935B (enExample)
MX (1) MX2009011284A (enExample)
MY (1) MY148092A (enExample)
NZ (1) NZ580482A (enExample)
PA (1) PA8776801A1 (enExample)
PL (1) PL2146714T3 (enExample)
PT (1) PT2146714E (enExample)
RS (1) RS51869B (enExample)
SI (1) SI2146714T1 (enExample)
TW (1) TWI439269B (enExample)
UY (1) UY31035A1 (enExample)
WO (1) WO2008145841A1 (enExample)
ZA (1) ZA200907251B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015006807A (es) * 2012-11-28 2016-01-14 Sanofi Sa Metodo de preparacion de formas cristalinas de la 4-(ciclopropilmetoxi)-n-(3,5-dicloro-1-oxidopiridin-4-il)-5-metox ipiridin-2-carboxamida y sus formas cristalinas.
US9624100B2 (en) 2014-06-12 2017-04-18 Apple Inc. Micro pick up array pivot mount with integrated strain sensing elements
CN122055155A (zh) * 2023-10-12 2026-05-15 美德阿利克斯株式会社 经皮吸收组合物
CN122421966A (zh) * 2023-10-12 2026-07-17 傲拓神经科学公司 用替伐普兰治疗神经精神病症

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193926A (en) * 1974-03-20 1980-03-18 Schering Aktiengesellschaft 4-(Polyalkoxy phenyl)-2-pyrrolidones
ZA945609B (en) * 1993-07-28 1995-05-12 Rhone Poulenc Rorer Ltd [Di(ether or thioether)heteroaryl or fluoro substituted aryl] compounds
US6177077B1 (en) * 1999-02-24 2001-01-23 Edward L. Tobinick TNT inhibitors for the treatment of neurological disorders
DE60018470T2 (de) * 1999-12-23 2006-02-16 Icos Corp., Bothell Cyclische amp spezifische phosphodiesterase inhibitoren
US20030069169A1 (en) * 2001-03-02 2003-04-10 Macor John E. Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders
US20060004056A1 (en) * 2002-07-02 2006-01-05 Bernard Cote Di-aryl-substituted-ethan pyridone pde4 inhibitors
NZ542670A (en) * 2003-03-12 2008-11-28 Celgene Corp N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
US20070049611A1 (en) * 2005-06-10 2007-03-01 Talamas Francisco X Phosphodiesterase 4 inhibitors
US20070021451A1 (en) * 2005-07-20 2007-01-25 Hamamatsu University School Of Medicine Method for preventing or treating neurologic damage after spinal cord injury

Also Published As

Publication number Publication date
US20100130554A1 (en) 2010-05-27
NZ580482A (en) 2011-10-28
AU2008257322A1 (en) 2008-12-04
MY148092A (en) 2013-02-28
ES2367408T3 (es) 2011-11-03
ATE513548T1 (de) 2011-07-15
ME00935B (me) 2012-06-20
SI2146714T1 (sl) 2011-10-28
TW200911247A (en) 2009-03-16
PL2146714T3 (pl) 2011-10-31
EP2146714A1 (fr) 2010-01-27
MX2009011284A (es) 2009-11-02
CN101663035A (zh) 2010-03-03
BRPI0810444A2 (pt) 2016-05-31
DK2146714T3 (da) 2011-10-10
IL201448A (en) 2014-08-31
CL2008001136A1 (es) 2009-01-16
EA200970970A1 (ru) 2010-02-26
PA8776801A1 (es) 2008-11-19
FR2915100A1 (fr) 2008-10-24
MA31367B1 (fr) 2010-05-03
IL201448A0 (en) 2010-05-31
KR20150004885A (ko) 2015-01-13
KR20090130059A (ko) 2009-12-17
CN101663035B (zh) 2012-06-20
TWI439269B (zh) 2014-06-01
ZA200907251B (en) 2011-04-28
KR101503942B1 (ko) 2015-03-18
JO2678B1 (en) 2013-03-03
UY31035A1 (es) 2008-11-28
WO2008145841A1 (fr) 2008-12-04
CA2684174C (fr) 2014-02-25
RS51869B (sr) 2012-02-29
FR2915100B1 (fr) 2009-06-05
JP5386478B2 (ja) 2014-01-15
PT2146714E (pt) 2011-09-02
EA019194B1 (ru) 2014-01-30
CA2684174A1 (fr) 2008-12-04
HK1141725A1 (en) 2010-11-19
CY1111840T1 (el) 2015-10-07
AU2008257322B2 (en) 2013-06-13
AR066108A1 (es) 2009-07-22
EP2146714B1 (fr) 2011-06-22
JP2010524906A (ja) 2010-07-22

Similar Documents

Publication Publication Date Title
EA201170018A1 (ru) Разагилин для изменения течения болезни паркинсона
MX2009012485A (es) Formulacion oral de nicotina amortiguada con aminoacidos.
JP2019524856A5 (enExample)
FI3504187T3 (fi) Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten
WO2013049751A3 (en) Methods and oral orthotic systems for use in connection with sleep - disordered breathing
DK1696904T3 (da) Anvendelse af rotigotin til behandling eller forebyggelse af dopaminergt neurontab
EP3904502A3 (en) Compositions and methods
EP2583978A3 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
UA99309C2 (ru) Замещенные пиперидинодигидротиенопиримидины
JP2015057451A5 (enExample)
WO2008131059A3 (en) Intranasally administering curcumin in a bolus of helium gas to treat alzheimer's disease
NZ595046A (en) Compositions and methods for extended therapy with aminopyridines
GEP20146080B (en) Chromone derivatives, method of their preparation and therapeutic applications
WO2008149802A1 (ja) アンドログラホリドを有効成分とする抗疲労剤及び経口組成物
PE20081106A1 (es) Comprimidos pediatricos de capecitabina
PL2244703T3 (pl) Lekarstwo, jego wytwarzanie i zastosowanie w leczeniu bolesnych neuropatii
HRP20130205T1 (hr) Sastavi koji sadrže apoekvorin i postupci njihove uporabe
MX340564B (es) Isoformas de neurregulina solubles activas modificadas post-traduccionalmente.
EA201390181A1 (ru) Несущий корпус для лекарственного средства и способ его изготовления
WO2008042314A3 (en) Diagnosis and treatment of disorders of the eye
RU2007122391A (ru) S-миртазапин для лечения приливов
CN102512257B (zh) 可摘局部义齿用联合短臂卡环
EA200970970A1 (ru) Применение 4-циклопропилметокси-n-(3,5-дихлор-1-оксидо-4-пиридин-4-ил)-5-(метокси)пиридин-2-карбоксамида для лечения моторных нарушений, связанных с болезнью паркинсона
JP2010524906A5 (enExample)
CN103349585B (zh) 磁力阻鼾器及其制造方法